References
- Gupta AK, Albreski D, Del Rosso JQ, Konnicov N. The use of the new oral antifungal agents, itraconazole, terbinafine, and fluconazole, to treat onychomycosis and other dermatomycoses. Curr Probl Dermatol 2001;13:220–46
- Nair AB, Vaka SRK, Murthy SN. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails. Drug Dev Ind Pharm 2011;37:1253–8
- Davis CP. Onychomycosis (Fungal Nail Infection). Available from: http://www.emedicinehealth.com/onychomycosis/article_em.htm [last accessed 09 Nov 2010]
- Baran R, Faergemann J, Har RJ. Superficial white onychomycosis – a syndrome with different fungal causes and path of infection. J Am Acad Dermatol 2007;57:879–82
- Rich P. An atlas of diseases of the nail. New York: CRC Press Co.; 2005
- Wilson JW, Plunkett OA. The fungus diseases of man. Berkeley: University of California Press; 1962:231–51
- Mertin D, Lippold BC. In vitro permeability of the human nail plate and of akeratin membrane from bovine hooves: influence of the partition coefficient octanol/water and the solubility of drugs on their permeability and maximum flux. J Pharm Pharmacol 1997;49:30–4
- Walters KA, Flynn GL, Marvel JR. Physicochemical characterization of the human nail: permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum. J Pharm Pharmacol 1983;35:28–33
- Hui X, Shainhouse Z, Tanojo H, et al. Enhanced human nail drug delivery: nail inner drug content assayed by new unique method. J Pharm Sci 2002;91:189–95
- Hardin TC, Graybill JR, Fetchick R, et al. Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrob Agents Chemother 1988;32:1310–13
- The Merk Index. Merk research laboratories. 13th ed. New Jersey: Division of Merk & Co. INC; 2001:5363
- Prakobvaitayakit M, Nimmannit U. Optimization of polylactic-co-glycolic acidnanoparticles containing itraconazole using 23 fractional design. AAPS Pharma Sci Tech 2003;4:1–11
- Nielloud F, Marti-Mestres G. Pharmaceutical emulsions and suspension. Vol. 105. New York: Marcel Dekker Inc.; 2000
- Hong JY, Kim JK, Song JK, et al. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release 2006;110:332–8
- Woo JS, Song YK, Hong JY, et al. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazolein healthy volunteers. Eur J Pharm Sci 2008;33:159–65
- Murdan S. Drug delivery to the nail following topical application. Int J Phama 2002;236:1–26
- Vellar OD. Composition of human nail substance. Am J Clin Nutr 1970;23:1272–4
- Rhee Y, Park C, Kim K, et al. Behavior of itraconazole and benzyl alcohol in aqueous solution containing nonionic surfactants. Arch Pharm Res 2007;30:240–8
- Shivakumar HN, Juluri A, Desai BG, Murthy SN. Ungual and transungual drug delivery. Drug Dev Indus Pharm 2012;38:901–11